Exchange: NASDAQ·Updated 07:30 PM EDT
ALZN logo

ALZN Alzamend Neuro Inc

$1.85
$0.05
(2.72%)
Today
Closed $1.89
$0.04
(2.12%)
After Hours
Reported EarningsSep 16
Mkt Cap$9.12M
Vol241,873.00

About ALZN

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.
61

Bullish Sentiment

How do you feel about ALZN?

Dcvcool
$ALZN this is such garbage. I’ll hold my short until their next dilution or reverse split. Should be longer than a year
2
hiwatt
$ALZN Lithium’s Undeniable Efficacy—Even in High-Risk Populations Lithium continues to be the most-researched, evidence-based, tried-and-true mood stabilizer for bipolar disorder. Its efficacy is demonstrated for acute mania, bipolar depression, and long-term relapse prevention, and it has a documented anti-suicide effect not shared by other agents. Meta-analytic data consistently show superior protection against mood episode recurrence and suicide compared with anticonvulsants and atypical antipsychotics, particularly in patients with classic bipolar disorder. Yet, the use of lithium has declined based on concerns about acute and chronic risk, particularly in populations such as the elderly, medically ill, and perinatal patients. However, many of lithium’s purported risks, which have contributed to its declining use, are not absolute contraindications.
2
hiwatt
$ALZN We are getting close to having a better insight, via the Telsa coil and a first ever side by side comparision of regular lithium vs AL001 in bipolar patents. Even though the market is generic, a safer, lower dosed, better efficacy drug can still prosper if priced competitive.
2
hiwatt
$ALZN Only thing of interest that I saw in the 10Q.---Clinical trial fees for the three months ended July 31, 2026 were for our Phase IIB clinical study on BD subjects conducted with MGH, which we expect to complete in September 2026.
2
PenkeInvesting
I looked at the business behind $ALZN (Alzamend Neuro, Inc.) for you. Based on financial data and reported results. #ALZN
austinhaleybop
$ALZN Todd straight up gangster on ALL his stocks what happened to his YYGH? it's gone!!!??? Joel help me
ka1954
$ALZN why u fucking idiots don't sell before close? now someone selling 31k in after hours 7% down?

Advertisement|Remove ads.